Sinopharm Group Co Stock Performance

SHTDF Stock  USD 2.35  0.00  0.00%   
The entity has a beta of 0.32, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sinopharm Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sinopharm Group is expected to be smaller as well. At this point, Sinopharm Group has a negative expected return of -0.12%. Please make sure to validate Sinopharm Group's jensen alpha, kurtosis, as well as the relationship between the Kurtosis and relative strength index , to decide if Sinopharm Group performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Sinopharm Group Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
Begin Period Cash Flow50.2 B
Total Cashflows From Investing Activities-1.3 B
Free Cash Flow9.3 B
  

Sinopharm Group Relative Risk vs. Return Landscape

If you would invest  253.00  in Sinopharm Group Co on October 28, 2025 and sell it today you would lose (18.00) from holding Sinopharm Group Co or give up 7.11% of portfolio value over 90 days. Sinopharm Group Co is currently producing negative expected returns and takes up 1.064% volatility of returns over 90 trading days. Put another way, 9% of traded pink sheets are less volatile than Sinopharm, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Sinopharm Group is expected to under-perform the market. In addition to that, the company is 1.44 times more volatile than its market benchmark. It trades about -0.11 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Sinopharm Group Target Price Odds to finish over Current Price

The tendency of Sinopharm Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.35 90 days 2.35 
about 98.0
Based on a normal probability distribution, the odds of Sinopharm Group to move above the current price in 90 days from now is about 98.0 (This Sinopharm Group Co probability density function shows the probability of Sinopharm Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Sinopharm Group has a beta of 0.32. This usually implies as returns on the market go up, Sinopharm Group average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Sinopharm Group Co will be expected to be much smaller as well. Additionally Sinopharm Group Co has an alpha of 0.0117, implying that it can generate a 0.0117 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Sinopharm Group Price Density   
       Price  

Predictive Modules for Sinopharm Group

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sinopharm Group. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sinopharm Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.292.353.41
Details
Intrinsic
Valuation
LowRealHigh
1.352.413.47
Details

Sinopharm Group Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sinopharm Group is not an exception. The market had few large corrections towards the Sinopharm Group's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sinopharm Group Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sinopharm Group within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.01
β
Beta against Dow Jones0.32
σ
Overall volatility
0.07
Ir
Information ratio -0.02

Sinopharm Group Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sinopharm Group for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sinopharm Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Sinopharm Group generated a negative expected return over the last 90 days

Sinopharm Group Fundamentals Growth

Sinopharm Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Sinopharm Group, and Sinopharm Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sinopharm Pink Sheet performance.

About Sinopharm Group Performance

By analyzing Sinopharm Group's fundamental ratios, stakeholders can gain valuable insights into Sinopharm Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sinopharm Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sinopharm Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm Group is traded on OTC Exchange in the United States.

Things to note about Sinopharm Group performance evaluation

Checking the ongoing alerts about Sinopharm Group for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Sinopharm Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sinopharm Group generated a negative expected return over the last 90 days
Evaluating Sinopharm Group's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Sinopharm Group's pink sheet performance include:
  • Analyzing Sinopharm Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sinopharm Group's stock is overvalued or undervalued compared to its peers.
  • Examining Sinopharm Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Sinopharm Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sinopharm Group's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Sinopharm Group's pink sheet. These opinions can provide insight into Sinopharm Group's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Sinopharm Group's pink sheet performance is not an exact science, and many factors can impact Sinopharm Group's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Sinopharm Pink Sheet analysis

When running Sinopharm Group's price analysis, check to measure Sinopharm Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinopharm Group is operating at the current time. Most of Sinopharm Group's value examination focuses on studying past and present price action to predict the probability of Sinopharm Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinopharm Group's price. Additionally, you may evaluate how the addition of Sinopharm Group to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements